Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017529
Filing Date
2022-11-14
Accepted
2022-11-14 06:05:53
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmbr-20220930x10q.htm   iXBRL 10-Q 1894221
2 EX-31.1 tmbr-20220930xex31d1.htm EX-31.1 17946
3 EX-31.2 tmbr-20220930xex31d2.htm EX-31.2 16230
4 EX-32.1 tmbr-20220930xex32d1.htm EX-32.1 8057
5 EX-32.2 tmbr-20220930xex32d2.htm EX-32.2 9582
  Complete submission text file 0001558370-22-017529.txt   8778114

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmbr-20220930.xsd EX-101.SCH 58705
7 EX-101.CAL tmbr-20220930_cal.xml EX-101.CAL 40326
8 EX-101.DEF tmbr-20220930_def.xml EX-101.DEF 333165
9 EX-101.LAB tmbr-20220930_lab.xml EX-101.LAB 491948
10 EX-101.PRE tmbr-20220930_pre.xml EX-101.PRE 455998
58 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20220930x10q_htm.xml XML 1691703
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 221379545
SIC: 2834 Pharmaceutical Preparations